Opus Capital Group’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $526K | Buy |
240,000
+500
| +0.2% | +$1.1K | 0.06% | 74 |
|
|
2025
Q1 | $259K | Buy |
239,500
+1,000
| +0.4% | +$1.08K | 0.03% | 105 |
|
|
2024
Q4 | $248K | Buy |
238,500
+12,400
| +5% | +$12.9K | 0.03% | 101 |
|
|
2024
Q3 | $283K | Buy |
226,100
+5,100
| +2% | +$6.38K | 0.04% | 95 |
|
|
2024
Q2 | $263K | Buy |
221,000
+20,400
| +10% | +$24.3K | 0.04% | 102 |
|
|
2024
Q1 | $203K | Buy |
200,600
+65,600
| +49% | +$66.4K | 0.03% | 118 |
|
|
2023
Q4 | $143K | Buy |
135,000
+100,500
| +291% | +$106K | 0.02% | 117 |
|
|
2023
Q3 | $57K | Buy |
34,500
+3,500
| +11% | +$5.78K | 0.01% | 111 |
|
|
2023
Q2 | $49K | Buy |
31,000
+6,000
| +24% | +$9.48K | 0.01% | 119 |
|
|
2023
Q1 | $36K | Buy |
25,000
+5,328
| +27% | +$7.67K | 0.01% | 119 |
|
|
2022
Q4 | $46K | Buy |
+19,672
| New | +$46K | 0.01% | 115 |
|